The development of modified release oral dosage forms (retard dosage forms) is one of the main goals of pharmaceutical industry for drugs having a short half-life. The rationale of these dosage forms would be the reduction of interdose fluctuations throughout 24 hours owing to the decreased number of daily administrations. Consequently, the incidence of side effects is reduced and the patient compliance is improved. The drug prescription both in conventional and in retard dosage forms has been analysed in order to evaluate the impact of modified release dosage forms over the period from January 1990 to July 1993. As the analysis of the prescriptions shows, the consumption of the retard dosage forms is regularly increased. Usually, the preference toward retard dosage forms is different according to the drug and does not appear affected by the cost of the therapy.

The prescription of modified release oral dosage forms / Vandelli, M. A.; Bernabei, M. T.; De Rosa, M.; Covezzoli, A.; Bianchi, G.. - In: GIORNALE ITALIANO DI FARMACIA CLINICA. - ISSN 1120-3749. - 9:1(1995), pp. 5-16.

The prescription of modified release oral dosage forms

Vandelli M. A.;
1995

Abstract

The development of modified release oral dosage forms (retard dosage forms) is one of the main goals of pharmaceutical industry for drugs having a short half-life. The rationale of these dosage forms would be the reduction of interdose fluctuations throughout 24 hours owing to the decreased number of daily administrations. Consequently, the incidence of side effects is reduced and the patient compliance is improved. The drug prescription both in conventional and in retard dosage forms has been analysed in order to evaluate the impact of modified release dosage forms over the period from January 1990 to July 1993. As the analysis of the prescriptions shows, the consumption of the retard dosage forms is regularly increased. Usually, the preference toward retard dosage forms is different according to the drug and does not appear affected by the cost of the therapy.
9
1
5
16
The prescription of modified release oral dosage forms / Vandelli, M. A.; Bernabei, M. T.; De Rosa, M.; Covezzoli, A.; Bianchi, G.. - In: GIORNALE ITALIANO DI FARMACIA CLINICA. - ISSN 1120-3749. - 9:1(1995), pp. 5-16.
Vandelli, M. A.; Bernabei, M. T.; De Rosa, M.; Covezzoli, A.; Bianchi, G.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1248416
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact